Inhibitors, alkaline phosphatase

Inhibitors should be removed from sample. An example is urinary phosphate, which can be removed by dialysis prior to measuring the urinary alkaline phosphatase activity (18). 

Select azole antifungals (e.g., itraconazole, voriconazole, and posaconazole) and the echinocandins are available for IA treatment. For initial therapy of IA, voriconazole had higher response and survival rates than c-AMB.102 An advantage of voriconazole is its 96% oral bioavailability, making use of this oral drug an attractive and less expensive alternative. The dose of voriconazole was 6 mg/kg IV every 12 hours for two doses, followed by 4 mg/kg IV every 12 hours for at least 7 days, at which time oral voriconazole 200 mg every 12 hours could be administered. Common toxicities reported with voriconazole include infusion-related, transient visual disturbances (i.e., blurred vision, altered color perception, photophobia, and visual hallucinations), skin reactions (i.e., rash, pruritus, and photosensitivity), elevations in hepatic transaminases and alkaline phosphatase, nausea, and headache.102 In addition, voriconazole increases the serum concentrations of medications cleared by cytochrome P-450 2C9, 2C19, and 3A4 (e.g., cyclophosphamide and calcineurin inhibitors) concomitant voriconazole-sirolimus should be avoided.103... 

A more successful strategy for developing sensitive and facile assays to monitor PLCBc activity involves converting the phosphorylated headgroup into a colorimetric agent via a series of enzyme coupled reactions. For example, phosphatidylcholine hydrolysis can be easily monitored in a rapid and sensitive manner by enzymatically converting the phosphorylcholine product into a red dye through the sequential action of alkaline phosphatase, choline oxidase, and peroxidase [33]. This assay, in which 10 nmol of phosphorylcholine can be readily detected, may be executed in a 96-well format and has been utilized in deuterium isotope and solvent viscosity studies [34] and to evaluate inhibitors of PLCBc [33] and site-directed mutants of PLCBc [35,36]. 

Note Do not use PBS for alkaline phosphatase-conjugated antibodies, since phosphate is an inhibitor of alkaline phosphatase. 

Not all inhibitors fall into either of these two classes but some show much more complex effects. An uncompetitive inhibitor is defined as one that results in a parallel decrease in the maximum velocity and the Km value (Figure 8.8). The basic mode of action of such an inhibitor is to bind only to the enzyme-substrate complex and not to the free enzyme and so it reduces the rate of formation of products. Alkaline phosphatase (EC 3.1.3.1) extracted from rat intestine is inhibited by L-phenylalanine in such a manner. 

The example of amprenavir, an HIV-1 protease inhibitor, shows that intestinal metabolism can also be used as a strategy to enhance the bioavailability of compounds. In the biopharmaceutics classification system (BCS), amprenavir can be categorized as a class II compound it is poorly soluble but highly permeable [51]. Fosamprenavir, the water-soluble phosphate salt of amprenavir, on the other hand, shows poor transepithelial transport. However, after oral administration of fosamprenavir, this compound is metabolized into amprenavir in the intestinal lumen and in the enterocytes mainly by alkaline phosphatases, resulting in an increased intestinal absorption [51, 174],... 

Sodium azide is a powerful inhibitor of HRP, but sodium azide can be used with alkaline phosphatase conjugated antibodies without harmful effects. In addition, tap water or water deionized with polystyrene resins may inactivate the enzyme conjugate. Only use distilled, deionized water Tween-20 may interfere with some antibody-antibody reactions or may wash the protein of interest off the membrane. Tween-20 may be left out of the washes, but this may result in increased background... 

Currently, only a handful of examples of unique protein carboxylate-zinc interactions are available in the Brookhaven Protein Data Bank. Each of these entries, however, displays syn coordination stereochemistry, and two are bidentate (Christianson and Alexander, 1989) (Fig. 5). Other protein structures have been reported with iyw-oriented car-boxylate-zinc interactions, but full coordinate sets are not yet available [e.g., DNA polymerase (Ollis etal., 1985) and alkaline phosphatase (Kim and Wyckoff, 1989)]. A survey of all protein-metal ion interactions reveals that jyw-carboxylate—metal ion stereochemistry is preferred (Chakrabarti, 1990a). It is been suggested that potent zinc enzyme inhibition arises from syn-oriented interactions between inhibitor carboxylates and active-site zinc ions (Christianson and Lipscomb, 1988a see also Monzingo and Matthews, 1984), and the structures of such interactions may sample the reaction coordinate for enzymatic catalysis in certain systems (Christianson and Lipscomb, 1987). 

Alkaline phosphatase Hypophosphatasia due to accumulation of inhibitors of mineralization such as pyrophosphate, and inability to raise phosphorus levels at the site of calcium-phosphorus deposition into hydroxyapatite... 

Firestone and Heath442 found that the alkaline phosphatase (ortho-phosphoric monoester phosphate hydrolase, EC 3.1.3.1) that is induced in cultured cells by dibutanoy 1-cAMP is not detectable in the presence of inhibitors of glycosylation, although messenger RNA is found in proportions that are comparable to those of noninhibited... 

Rare adverse effects of fibrates include rashes, gastrointestinal symptoms, myopathy, arrhythmias, hypokalemia, and high blood levels of aminotransferases or alkaline phosphatase. A few patients show decreases in white blood count or hematocrit. Both agents potentiate the action of coumarin and indanedione anticoagulants, and doses of these agents should be adjusted. Rhabdomyolysis has occurred rarely. Risk of myopathy increases when fibrates are given with reductase inhibitors. The use of fenofibrate with rosuvastatin appears to minimize this risk. Fibrates should be avoided in patients with hepatic or renal dysfunction. There appears to be a modest increase in the risk of cholesterol gallstones. 

The X-ray crystal structure of the inorganic phosphate (an inhibitor) complex of alkaline phosphatase from E. coli (9) showed that the active center consists of a Zn2Mg(or Zn) assembly, where the two zinc(II) atoms are 3.94 A apart and bridged by the bidentate phosphate (which suggests a phosphomonoester substrate potentially interacting with two zinc(II), as depicted in Fig. 2), and the Mg (or the third Zn) is linked to one atom of the zinc pair by an aspartate residue at a distance... 

Fiqtire 3.5 (a) Competitive inhibition inhibitor and substrate compete for the same binding site. For example, indole, phenol, and benzene bind in the binding pocket of chymotrypsin and inhibit the hydrolysis of derivatives of tryptophan, tyrosine, and / phenylalanine, (b) Noncompetitive inhibition inhibitor and substrate bind simultaneously to the enzyme. An example is the inhibition of fructose 1,6-diphosphatase by AMP. This type of inhibition is very common with multisubstrate enzymes. A rare example of / uncompetitive inhibition of a single-substrate enzyme is the inhibition of alkaline phosphatase by L-phenylalanine. This enzyme is composed of two identical subunitjs, so presumably the phenylalanine binds at one site and the substrate at the other. [From N. K. Ghosh and W. H. Fishman, J. Biol. Chem. 241, 2516 (1966) see also M. Caswell and M. Caplow, Biochemistry 19, 2907 (1980). 

Different tissues contain different isoenzymes of alkaline phosphatase, and the intestinal isoenzyme is not inhibited by levamisole The enzyme used in immu-nohistochemistry is extracted from calf intestine, so that levamisole can be used as an inhibitor without affecting the desired reaction. For labile antigens in the intestine, it is better to switch to the peroxidase method. 

There are few potent competitive inhibitors for alkaline phosphatase (Table VII) (4, 21, 94, 96, 100, 105-109). Phosphate, thiophosphate, and arsenate have low values for KThese substances are actually substrates and can form a covalent intermediate. However, this is probably not the reason why they are potent inhibitors since in the case of phosphate the Michaelis complex is more stable than the covalent intermediate (30). The values of Kt for phosphate and arsenate at various pH values have been published (SO, 106, 110). 

The relationship between the various tissue alkaline phosphatases has been under discussion for many years (24). Bodansky established that inhibition by bile acids could be used to distinguish between intestinal and bone or kidney isoenzymes (25). The organ-specific behavior of rat tissue phosphatases toward a variety of compounds was investigated by Fishman (26). Of particular importance was the observation that l-phenylalanine is a stereospecific inhibitor for the intestinal isoenzyme (27). Immunochemical (28, 29) and electrophoretic techniques (30, 31) have shown that there are also physical differences between the tissue phosphatases. It is not yet clear what the precise nature of these differences is (32), although in part it results from a variability in sialic acid content. 

An important inhibitor of alkaline phosphatase is Pi, normally a very effective competitor with an affinity comparable to that for good substrates (107, 117). In consequence the kinetics of hydrolysis are often approximately first order whatever the substrate concentration, and for this reason initial rate measurements should be limited to 10% hydrolysis. With poor substrates, e.g., phosphocreatine (113) or o-carboxyphenyl phosphate (176), additional care is required. Arsenate is an even more powerful competitive inhibitor (101a, 118) and can prevent the incorporation of Pi by intestinal phosphatase at pH 5 (169). Phosphonates have been reported as weak inhibitors of intestinal phosphatase (120), and one has been used recently as a chromophoric probe for E. coli phosphatase (177). 

---